Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

MustGrow Biologics receives TerraSante approvals in Texas, Utah and Montana

MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF, FRA:0C0) announced that it has received registration approvals from agriculture departments in Texas, Utah, and Montana for sales of its organic biofertility product, TerraSante.

The company said the approvals allow it to begin commercial sales of the mustard-derived product in the three states.

TerraSante is already covered under MustGrow’s existing Organic Materials Review Institute (OMRI) certifications in Georgia, Florida, Arizona, Idaho, Oregon, and Washington.

MustGrow described TerraSante as an organic biofertility product designed to improve crop yields and soil health. The company said infield grower data has shown the product may also support soil microbiome health and improve nutrient and water-use efficiencies.

The company highlighted Texas as a potentially important market due to its large agricultural sector and high-value crop production.

According to figures cited by MustGrow, Texas agricultural production in 2025 included melons valued at $108 million, potatoes at $104 million, pecans at $85 million, and grapefruits at $59 million.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK